Relationship of morphometric parameters of the vacular membrane and blood supply of the eye in patients with age-related macular degeneration

Korol, A.; Khramenko, N.; Zadorozhnyy, O.; Kustrin, T.

doi:10.31288/oftalmolzh201332326

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The AMD treatment and prevention strategy involving iontophoresis with citicoline is based on the following fact: antioxidant, neuroprotective, anti-edema and antiangiogenesis processes play the major role in the targeted medicamentous influence on the retina and choroid [4]. Therefore, introducing the drug with antioxidative and neuroprotective effect into the management of DMPP is a pathogenetically targeted and reasonable approach [7,8].…”

Section: Resultsmentioning

confidence: 99%

“…The risk of DMPP increases 3-fold in the presence of atherosclerosis, and 7-fold in the presence of hypertonic disease. In addition, most AMD patients have been found to exhibit decreased regional blood supply [3][4][5], which correlated with decreased choroidal thickness. Early and adequate treatment may stabilize visual functions and prevent the development of blindness in these patients.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

On the treatment of degeneration of the macula and posterior pole

Konovalova¹,

Khramenko²,

Guzun³

et al. 2018

Oftalmol Zh

Self Cite

View full text Add to dashboard Cite

The field of degeneration of the macula and posterior pole (DMPP) is of outstanding medical and social significance as the disease is of high prevalence and leads to loss of general working capacity. Purpose: To determine the efficacy of conservative treatment with endonasal iontophoresis of Omk2, and the degree of stabilization of visual functions after this treatment in patients with DMPP. Materials and Methods: Thirty-two patients (45 eyes; age, 51 to 75 years) with DMPP were examined and received treatment with endonasal iontophoresis of Omk2. The eye examination included visual acuity, retinal light sensitivity, threshold assessment with macula tester, perimetry and ophthalmoscopy, and was performed before and after treatment. Results: In all patients with DMPP, iontophoresis of Omk2 contributed to apparent improvement in functional activity of the retina, which was achieved due to antioxidative, neurotropic, anti-edema and anti-angiogenetic properties of the drug. In particular, mean uncorrected visual acuity (UCVA) in patients of group 1 improved by 25%, from 0.6 to 0.85, and UCVA in 49% of patients of group 2 improved by 0.01-0.02, which improved the level of social rehabilitation of these patients. In patients with DMPP, the treatment with iontophoresis of Omk2 resulted in improvements in the functional activity of the retinal photopic system and foveal afferent system (as assessed by the Haidinger's brushes test), and retinal blood flow in the posterior pole (as assessed by the blue field technique) by 33-43%, 14%, and 40%, respectively. This demonstrates that the treatment strategy has the beneficial impact on the function of the visual system, and iontophoresis of Omk2 is a pathogenetically reasonable approach to the management of DMPP. Conclusion: Iontophoresis of Omk2 was found to be beneficial for the function of the visual system, and a pathogenetically reasonable approach to the management of DMPP.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%